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Background: Social support plays an important role for health outcomes. Support
for those living with chronic conditions may be particularly important for their health,
and even for their survival. The role of support for the survival of cancer patients after
receiving an allogeneic hematopoietic cell transplant (alloHCT) is understudied. To better
understand the link between survival and support, as well as different sources and
functions of support, we conducted two studies in alloHCT patients. First, we examined
whether social support is related to survival (Study 1). Second, we examined who
provides which support and which specific support-related functions and tasks are
fulfilled by lay caregivers and healthcare professionals (Study 2).
Methods: In Study 1, we conducted a retrospective chart review of alloHCT patients
(N = 173, 42.8% female, age: M = 49.88) and registered availability of a dedicated
lay caregiver and survival. In Study 2, we prospectively followed patients after alloHCT
(N = 28, 46.4% female, age: M = 53.97, 46.4% ethnic minority) from the same hospital,
partly overlapping from Study 1, who shared their experiences of support from lay
caregivers and healthcare providers in semi-structured in-depth interviews 3 to 6 months
after their first hospital discharge.
Results: Patients with a dedicated caregiver had a higher probability of surviving to
100 days (86.7%) than patients without a caregiver (69.6%), OR = 2.84, p = 0.042.
Study 2 demonstrated the importance of post-transplant support due to patients’
emotional needs and complex self-care regimen. The role of lay caregivers extended
to many areas of patients’ daily lives, including support for attending doctor’s
appointments, managing medications and financial tasks, physical distancing, and
maintaining strict dietary requirements. Healthcare providers mainly fulfilled medical
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needs and provided informational support, while lay caregivers were the main source of
emotional and practical support.
Conclusion: The findings highlight the importance of studying support from lay
caregivers as well as healthcare providers, to better understand how they work together
to support patients’ adherence to recommended self-care and survival.
Keywords: allogeneic hematopoietic cell transplant, cancer, caregiver support, healthcare providers, multiple
medication adherence, social support, survival, self-care
INTRODUCTION
Social support has long been recognized as a key contributor to
health (Berkman et al., 2000; Uchino, 2006; Holt-Lunstad et al.,
2010). It is associated with higher quality of life and even survival
in cancer (Chou et al., 2012; Aizer et al., 2013; Luszczynska
et al., 2013). For recipients of an allogeneic hematopoietic
cell transplant (alloHCT, commonly used to treat blood and
lymphoid cancers), social support is especially critical. Many
hematopoietic cell transplant programs require a caregiver
to become eligible for transplant (National Marrow Donor
Program, 2017; Preussler et al., 2019). However, so far, there is
conflicting evidence regarding the impact of social support on
survival after alloHCT.
A systematic review by Beattie et al. (2013) contained six
studies published before 2011 in this population, while we
identified six additional recent studies in our literature update.
Four studies found that patients with social support after
transplant had higher rates of survival than those without support
(Colón et al., 1991: N = 100 patients after alloHCT, 55 vs. 20% at
24 months; Frick et al., 2005: N = 99 patients after autologous
transplant, 78 vs. 40% at 47 months; Foster et al., 2005: N = 131
patients after alloHCT, 54 vs. 15%; Foster et al., 2013, also
reported in McLellan et al., 2011: N = 164 alloHCT patients, 42 vs.
26%). Foster et al., 2013 highlighted the importance of longer and
more frequent visits from a dedicated lay caregiver for survival,
contrasted with merely having a support system. Another study
(N = 92, 46% after alloHCT and 54% after autologous transplant)
did not report enough information to calculate survival rates
but found higher survival with better support (Rodrigue et al.,
1999). AlloHCT patients with at least one close and dependable
relationship partner survived for longer after transplant than
those with poorer support pre-transplant (N = 400, HR = 0.57
over 2 years; Ehrlich et al., 2016). Patients after alloHCT who
were single showed shorter survival times than those married
or in committed relationships (N = 130 over a median follow-
up of 713 days, HR = 1.91; Pillay et al., 2014). Another recent
study found a non-significant tendency that support stability and
support availability were related to survival in a smaller sample
of 119 patients after alloHCT (HR = 1.29 and 1.23 over a median
follow-up of 721 days; Harashima et al., 2019).
While considerable evidence indicates that support matters,
some studies found no link between support or marital status
and survival. An unpublished dissertation with a large sample did
not find an association between support and survival (N = 272
patients, 83% after alloHCT, 17% after autologous transplant;
Artherholt, 2007). Three additional studies that used marital
status as a support indicator failed to find a link with survival
in large samples of patients after alloHCT (N = 10,226, Tay
et al., 2020; N = 715, Gerull et al., 2017; N = 309; Sato
et al., 2018). However, two of these studies still found some
evidence that social support could matter for survival: Tay
et al. (2020) found an association for graft-versus-host disease
(GvHD), while Gerull et al. (2017) found that patients with
missing information on marital status had worse survival than
those with available information.
The available evidence leaves considerable gaps. Larger studies
relied on marital status as a support indicator, while smaller
studies used more elaborate and nuanced measures. Overall,
social support was not consistently measured, with marital status
likely being too coarse a measure for support, as it ignores other
sources than the spouse (such as parents, siblings, or children,
Foster et al., 2013; Sato et al., 2018; Preussler et al., 2019).
Taken together, the mixed outcomes of the available studies and
varying indicators of social support suggest the need for a deeper
understanding of the characteristics of caregivers and functions
of social support in patients after alloHCT (Beattie et al., 2013;
Tay et al., 2019).
Patients after transplant experience high mortality due to
potentially life-threatening complications, infections, GvHD, and
cancer recurrence (Pasquini and Wang, 2011; Holtan et al., 2015).
Patients are prescribed a complex self-care regimen to improve
survival rates, including procuring and taking 18 or more
different medications, frequent hospital visits, and following
strict dietary, hydration, and hygiene requirements including
social distancing (Tomblyn et al., 2009; Morrison et al., 2017).
However, adherence to this complex regimen has not been ideal.
A study following 376 alloHCT recipients found that almost
two-thirds were non-adherent in taking immunosuppressant
medication (Kirsch et al., 2014), while 54.6% of alloHCT patients
were poorly adherent to their medication regimens in a recent
pilot study (Lehrer et al., 2018).
Reviews of the existing literature, examining both structural
and functional support, found that social support, especially
practical support provided by close others, was linked to better
adherence (DiMatteo, 2004; Scheurer et al., 2012). A recent
review of 52 studies in hematological cancer patients found
that social support was associated with medication adherence
(Hall et al., 2016). A study of 21 alloHCT patients and their
partners found varying rates (19 to 100%) of adherence to
various post-transplant self-care tasks, with adherence levels
dependent on which dyad member was responsible for the task
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(Posluszny et al., 2018). There are few studies examining support
from healthcare providers (Hall et al., 2016), with available
studies suggesting that patient-physician communication and
relationship quality are linked to patient adherence to treatment
and medications (Haskard Zolnierek and DiMatteo, 2009; Hillen
et al., 2010; Espinosa and Kadić-Maglajlić, 2019).
We conducted two studies in alloHCT patients to address gaps
in the literature. In Study 1, we conducted a retrospective chart
review to examine whether social support is related to survival. In
Study 2, we conducted a prospective study at the same hospital to
examine characteristics of lay caregivers and healthcare providers
and the types of support they provide to alleviate distress and
facilitate patients’ adherence to prescribed self-care.
STUDY 1: SUPPORT AND SURVIVAL IN
ALLOHCT PATIENTS




The study took place at a large urban teaching hospital which
serves a diverse population and has a well-established transplant
program delivering alloHCT. The program requires the patient
to name a caregiver to become eligible for alloHCT. The research
team conducted a retrospective chart review study. Patients
were eligible for inclusion in the chart review if they were at
least 18 years old and had received their first alloHCT between
February 26, 2009 and August 28, 2013. The research team then
coded survival data for up to 6 months until February 28, 2014.
Patients with identical dates for birth, treatment receipt, or death
were individually examined and duplicates due to data entry
errors removed, resulting in data from 173 participants eligible
for inclusion in these analyses. The local Institutional Review
Board of the hospital from which the data were collected reviewed
and approved the study (HS# 13-00761).
Measures
Members of the hospital team abstracted information from
patient charts, including patient background information on age,
gender, minority background, cancer type, and transplant donor
type. Support was assessed with data from the hospital database
(Epic). A member of the research team consulted the “next of
kin” information on the first page of each patient chart (“snapshot
view”) that the study team used in Study 2 to contact caregivers
to schedule appointments; it is also used in clinical care, for
example, to inform others should the patient pass away or in
case of financial matters. This field is filled out by the admission
team when a patient is admitted for transplant. We coded support
available if there was someone listed in this field (0 = no, 1 = yes).
Additionally, if there was no one listed or if the person listed
didn’t match up with the clinicians’ recollection of the caregiver,
the staff member read through the Social Work notes, and coded
“1” if there was mention of a caregiver consistently involved or
0 if there was no one listed. Due to the placement on the first
page of each patient chart, its use for clinical work as well as
hospital finances, and our own observation of its validity in Study
2, we assume that the coded information reflects the availability
of support to patients after alloHCT.
Survival was calculated based on the number of days between
first transplant and the date when the chart review was completed
(February 28, 2014), if the patient was still alive, or date of
death, if the patient had died before that point in time. Survival
to 100 days and to 180 days was coded as a binary variable
(0 = no, 1 = yes). Because patients receive continuing care at the
transplant clinic over an extended period of time and the clinic
reported patient outcomes to a national database, the abstracting
team was able to resolve nearly all issues with missing data or
data entry errors.
Data Analysis
We ran logistic regressions predicting survival to 100 days and
to 180 days, with the main predictor availability of a caregiver
(caregiver available: 1 = yes, 0 = no). In additional analyses, we
adjusted for covariates which are relevant for survival, such as
age (centered at the grand mean), gender (also centered at the
grand mean), minority background (1 = yes, 0 = no), cancer type
(leukemia 1 = yes, 0 = no), and transplant donor (with HLA-
identical sibling transplant, coded 1 = yes, 0 = no). All analyses
were conducted with IBM SPSS version 26.0 with a significance
level of p < 0.05.
Results
Characteristics of Patients
In total, 173 patients (42.8% female, age: M = 49.88) received an
alloHCT for the first time in the chart review period. The sample
was ethnically diverse, with half of the participants coming from
a minority background (n = 90, 52.0%; Non-Hispanic White:
48.0%, African American: 10.4%, Asian: 15.6%, Hispanic: 26.0%.
A majority of patients had leukemia as cancer type (85.0%). The
allogeneic cells for the transplant came in one of three patients
from an HLA-identical sibling (36.4%).
Support and Survival
Patients’ hospital files mentioned a dedicated caregiver in the
patient chart for 150 patients (88.2%), while 23 patients (11.2%)
did not have a dedicated caregiver listed. Of the 173 patients
analyzed, 146 (84.4%) survived to 100 days after their first
transplant, and 123 (71.1%) to 180 days.
Patients with a dedicated caregiver had a higher probability of
surviving to 100 days (86.7%) than patients without a caregiver
(69.6%), as logistic regression analysis showed, OR = 2.84,
p = 0.042. Multiple logistic regression indicated that this effect
was robust, OR = 3.03, p = 0.044, adjusting for covariates
that explain variation in survival, such as age, gender, minority
ethnic background, cancer type, and HLA-identical sibling
transplant (see Tables 1 and 2 Part a). In line with prior
studies, younger patients and those who were able to obtain an
HLA-identical sibling transplant showed a higher probability of
surviving to 100 days.
At 180 days, more patients had passed away, and the
effect sizes were somewhat smaller and non-significant,
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TABLE 1 | Availability of caregiver and frequencies and probabilities of surviving to




(a) Surviving to 100 days
Caregiver No 7 16 23 69.6
Yes 20 130 150 86.7
Total 146 173
(b) Surviving to 180 days
Caregiver No 10 13 23 56.5
Yes 40 110 150 73.3
Total 123 173
yet showed the same pattern of results: Patients with a
dedicated caregiver had higher chances of surviving to
180 days (73.3%) than patients without a caregiver (56.5%),
OR = 2.12, p = 0.103, with nearly identical effect size
after adjusting for covariates, OR = 2.15, p = 0.103 (see
Tables 1, 2, Part b).
Discussion
Study 1 found that the availability of a dedicated caregiver was
related to a 17.1% higher rate of surviving to 100 days after
transplant, compared to transplant recipients who did not have
a dedicated caregiver. Support from a dedicated caregiver in
the first months after leaving the hospital seems particularly
important, as patients are learning to adapt to the complex
self-care regimen. The effect size for survival at 180 days was
similar although not significant. The findings are in line with
the previous literature, demonstrating that the presence of a lay
caregiver was an important factor for survival after transplant
(Foster et al., 2005, 2013; McLellan et al., 2011; Beattie et al.,
2013) and related to longer survival after transplant (Hoodin
et al., 2006; Pillay et al., 2014). We assume that the patients
who had a dedicated caregiver recovered better and survived
at higher rates after transplant because they were more able
to follow the complex life-saving self-care regimen with the
help from their caregivers (Ehrlich et al., 2016; Posluszny et al.,
2018). In order to better understand the role of support in
self-care, Study 2 examined the sources and functions of social
support in depth.
STUDY 2: A CLOSER LOOK AT SUPPORT
FOR ALLOHCT PATIENTS’ SELF-CARE
Study 2 zooms in on the characteristics, support functions and
tasks of lay caregivers and healthcare providers.
TABLE 2 | Availability of caregiver and surviving to 100 and 180 days after transplant, logistic regression without and with adjusting for covariates (N = 173).
b SE Wald df p OR 95% CI
Lower Upper
(a) Surviving to 100 days
Univariate logistic regression
Intercept 0.83 0.45 3.33 1 0.068 2.29
Caregiver 1.05* 0.51 4.15 1 0.042 2.84 1.04 7.77
Multiple logistic regression
Intercept 1.56 0.93 2.80 1 0.094 4.76
Caregiver 1.11* 0.55 4.05 1 0.044 3.03 1.03 8.90
Age −0.43 0.19 4.88 1 0.027 0.65 0.45 0.95
Gender −0.41 0.46 0.79 1 0.375 0.67 0.27 1.63
Ethnic minority −0.53 0.50 1.13 1 0.289 0.59 0.22 1.56
Cancer type −0.71 0.82 0.74 1 0.388 0.49 0.10 2.46
HLA-identical sibling transplant 1.49 0.59 6.46 1 0.011 4.44 1.41 14.01
(b) Surviving to 180 days
Univariate logistic regression
Intercept 0.26 0.42 0.39 1 0.533 1.30
Caregiver 0.75 0.46 2.66 1 0.103 2.12 0.86 5.21
Multiple logistic regression
Intercept 0.44 0.67 0.43 1 0.513 1.55
Caregiver 0.77 0.47 2.66 1 0.103 2.15 0.86 5.42
Age −0.16 0.14 1.26 1 0.261 0.85 0.65 1.13
Gender −0.01 0.36 0.00 1 0.968 0.99 0.49 2.00
Ethnic minority 0.21 0.38 0.31 1 0.580 1.24 0.58 2.62
Cancer type −0.54 0.55 0.99 1 0.320 0.58 0.20 1.70
HLA-identical sibling transplant 0.56 0.38 2.25 1 0.134 1.76 0.84 3.66
b, regression weight; SE, standard error; Df, degrees of freedom; p, significance level; OR, odds ratio; CI, confidence interval with lower and upper limit.
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Methods
Setting and Participants
Study 2 is a prospective qualitative study in the same patient
population at the same hospital as in Study 1 with partly
overlapping participants. During the study period, 84 adult
patients received an alloHCT at the study site and they were all
invited to participate in the study by the doctors. 7 patients (8.3%)
were ineligible for participation because of language barriers (all
materials were available in English, Spanish, and Mandarin). The
recruitment rate was high, as about half (n = 38, 49.4%) of the
eligible patients (n = 77, 91.7%) agreed to participate and signed
consent. However, of the consented patients (n = 38), five patients
did not participate in the data collection: One patient passed
away prior to discharge; one patient had a complicated recovery
with many hospitalizations; and three patients withdrew from the
study before discharge. Data collection began with 33 patients
(42.9%), but five patients were not interviewed for the following
reasons: three patients deceased before interview, one was not
available for interview and another one was too ill to conduct
interview. Thus, we included 28 patients (84.8% of those from
whom we started collecting data) in our qualitative analyses.
We interviewed patients (N = 28) three to 6 months
after their first discharge from the hospital after receiving an
alloHCT. Eligible patients were invited by healthcare providers
to participate in the study during pre-transplant visits or during
their hospitalization after transplant. Individuals were eligible
for the study if they were blood or lymphoid cancer patients,
scheduled to receive an alloHCT, at least 18 years old and spoke
English, Spanish or Mandarin. As already mentioned in Study
1, the hospital requires naming a caregiver for eligibility for
alloHCT. Two of the interviews were conducted in Spanish
(7.1%), the rest in English (n = 26, 92.9%) and none in Mandarin.
Participation was voluntary. All patients were prescribed a
multiple medication regimen (typically consisting of 18 or more
different medications with 24 or more pills per day to prevent or
treat GvHD, fungal and bacterial infection, and irritation of the
digestive system) as a part of the self-care regimen after discharge
which also included frequent hospital visits, and abiding by
strict dietary and hydration requirements and hygiene regimens
including social distancing (Tomblyn et al., 2009; Morrison et al.,
2017). The local Institutional Review Board of the hospital from
which the data were collected reviewed and approved the study
(HS# 12-00453). All participants provided written informed
consent prior to participation. The study team complied with
the relevant standards in reporting results (Tong et al., 2007,
2012; Creswell et al., 2011; O’Brien et al., 2014) and followed the
COREQ guideline (Tong et al., 2007) closely (see Appendix A).
Measures
Semi-structured in-depth interviews were conducted.
Interviewers followed a structured interview guide (see Appendix
B) and probed individuals for detailed answers about their self-
care regimen and social support. The interview guide was
developed by the principal investigator, who is an expert in
health psychology. Interview questions covered various domains
related to individuals’ self-care regimen, including questions on
social support from lay caregivers and healthcare providers. The
interview guide contained the following main questions (see
Appendix B for a complete list including additional probes).
• Can you share with me a little bit about how life has changed
for you since your transplant?
• Who in your life knows that you are taking medication?
Are there people in your life who support you taking your
medications? Are there people in your life who help to make
sure that you take your medication on time?
• How have your eating and drinking habits changed since
the transplant?
• Does anyone help you with the pillbox? Who, specifically,
helps you? How do they help you?
• Does a lack of money ever make it difficult for you to take
your medication? Can you tell me about this? What do you
do about it?
• Tell me about your healthcare provider(s). Who is
the person who primarily treats you? What is your
relationship like with your care provider? Do you think
your relationship with your care provider makes it easier or
harder to take your medication? How so? Do you feel like
your care provider understands your needs?
To ensure the quality of the interviews, interviewers were
trained by the principal investigator; the interview questions were
pilot tested during role-play interviews prior to conducting actual
interviews with patients. All research assistants at the time had a
bachelor’s or master’s degree in social sciences, public health, or
health sciences.
Procedures
Participants who agreed to participate in the study and signed
written informed consent forms were contacted in advance to
schedule each interview. Individual semi-structured interviews
were conducted between three to 6 months after patients’
first discharge from hospital. Interviews were conducted either
in person before hospital appointments and/or via telephone
when participants could not manage hospital visits or preferred
telephone interviews. In some cases, the caregiver also joined the
interview when accompanying the participant to appointments.
Interviews lasted from 40 to 60 min and participants could
take a break if desired. All interviews were conducted by two
interviewers, with one interviewer asking questions and the other
taking notes and recording the interview. All the interviews
were audio recorded and transcribed. The audio recordings were
deleted after transcription. Data were kept in a secure password
protected drive. Participant were made aware of and agreed to
being recorded at the beginning of the interview. All confidential
information in the interview transcripts was removed and
replaced with generic titles (e.g., nurse Jane Doe with Nurse 1).
Data Analysis
Data on support from healthcare providers was missing for two of
the 28 participants because the participants felt too sick or could
not finish the interview for other reasons. Thus, percentages
are calculated based on 26 interviews for information regarding
support from healthcare providers. All interview transcripts were
read carefully and coded in NVivo version 11. One of the authors
Frontiers in Psychology | www.frontiersin.org 5 March 2021 | Volume 12 | Article 624906
fpsyg-12-624906 March 23, 2021 Time: 12:12 # 6
Song et al. Support, Survival and Self-Care
(YS) selected seven interviews from the 28 patients (25%) to
represent the sample as best as possible and two coders (YS and
SC) coded individually if an interview contained information
about support from lay caregivers and healthcare providers. The
coders met several times with the project lead (GS) to go over
the coding and discuss the discrepancies until the two were in
agreement. We calculated kappa coefficient based on a binary
coding if support from a lay caregiver and a healthcare provider
was mentioned by the patient (mentioned: 1 = yes, 0 = no).
Kappa coefficients for support from lay caregivers and support
from healthcare providers were calculated separately. The kappa
for sources of support (lay caregivers’ support mentioned,
yes/no; healthcare provider support mentioned: yes/no) was in
agreement (κ = 1.00). The finer coding of the subcategories of
social support used thematic analysis (Braun and Clarke, 2006).
The coding scheme initially followed classical social support
theory, including instrumental, emotional and informational
support (Weiss, 1974; Cohen and McKay, 1984; House et al.,
1985; Thoits, 2011). Two coders (YS and SC) coded relevant
quotes on social support. to identify the meanings in the
interviews and analyze the data. While reading through the
interviews for coding the coders identified additional themes,
so added codes for the following themes: meaning in life,
financial support from lay caregivers, and support with medical
needs from healthcare providers. An initial category with the
working title “Lack of support” was modified and renamed to
ambivalence about support. A codebook was developed listing
different themes, definitions, and examples (see Appendix C).
All interview transcripts and relevant quotes were carefully read
again by one of the researchers (YS) to calculate the number of
patients and percentage of total participants that had mentioned
a specific theme at least once.
Results
In total, 28 individuals (46.4% female, age: M = 53.97)
participated in the interviews. The sample was ethnically
diverse, with almost half of the participants coming from a
minority background (n = 13, 46.4%): Non-Hispanic White:
53.6%, African American: 7.1%, Asian: 17.9%, Hispanic:
17.9%, other: 3.6%.
Characteristics of Lay Caregivers
Lay caregivers, such as family members and friends, were the
primary source of social support for transplant recipients. All
participants reported receiving support from family members,
friends, or acquaintances (n = 28/28, 100.0%). Moreover, about
half of the participants reported to have at least one primary
source of support, usually a spouse or partner, who was their
main caregiver over the course of the transplant (n = 15/28,
53.6%, see Figure 1). For example, a participant mentioned that
his wife supported him in taking his medications (P13, male).
Another participant mentioned, “My husband does everything!
He’s actually on top of everything more than I am.” (P07, female)
A considerable number of transplant recipients (n = 11/28,
39.3%) reported relying on several lay caregivers, such as the
partner and other family members (n = 6/28, 21.4%), family
members other than the partner (n = 4/28, 14.3%), or family
members and friends (n = 1/28, 3.6%). One of the participants
mentioned that his whole family ensures that he takes his
medications regularly on time (P14, male). Another participant
mentioned,
Well, yes mymother, I talk to her every day, three times a day, again
my son, my boyfriend, (. . . ) so yes, I have a lot of people supporting
me, asking me this, did I do this. (P31, female)
Additionally, in two cases, acquaintances or non-family
members supported individuals after transplant as lay caregivers
(n = 2/28, 7.1%). One of them mentioned,
The helpers are mainly people from my [place of worship]. I have
a woman who accompanies me to all my visits. Since my first
transplant she has gone to every appointment with me. She brings
lunch and meals and snacks. And uh, there’s a team of persons
who provide me what I need in terms of food and stuff like that.
So they’ve been very helpful. Um. . .I have a staff. A secretary, a
bookkeeper, a staff in the kitchen. They do parts just to make sure.
To get my car moved, get my mail, someone to go to the bank. So
they take care [of] all those things. (P19, male)
Regardless of the type of their connection to the patient,
patients described lay caregivers as essential for post-transplant
recovery. For some patients after transplant (n = 4/28, 14.3%) this
extended into experiencing new meaning in life, with life after
transplant perceived as an opportunity to love and be with loved
ones. A participant mentioned,
I have grown to love everything (. . .) I have taken advantage of
time spent with my children, putting more attention to everything
in life and being appreciative of God each and every day. (P23,
female)
Types of Support From Lay Caregivers
Lay caregivers supported individuals after transplant in three
main ways, instrumental, emotional, and informational support,
with some patients noting some ambivalence about receiving
support (see Table 3 for an overview). We will present each type
of support with examples. Regarding instrumental support, lay
caregivers had a wide range of tasks to help the patients with from
daily living, financial matters to medication intake, to reduce the
risk of infection in the immunosuppressed patients.
[My] husband does all the homework. He cooks, I don’t. Doctor
doesn’t want me to have outside food. He reminds me to take the
medication, he reminds me almost every time. (P11, female)
Instrumental support for daily living is vital as individuals
after transplant must reduce their exposure to all possible sources
of infection. This includes eating cooked foods only, watching
what they drink and touch, and maintaining physical distance
from people while managing side effects and other physical
complications (Beattie and Lebel, 2011). Instrumental support
for daily living from lay caregivers is crucial, including driving,
cooking, getting groceries, and fulfilling daily practical needs
(n = 16/28, 57.1%).
One participant mentioned,
Fortunately, my father helps me out with the transportation most
of the time, so I don’t have to rely on public transportation. So, I
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FIGURE 1 | Primary support providers individuals after transplant (n = 28).
TABLE 3 | An overview of the type of support, definition and number of patients reporting it (N = 28).
Types of support Definition N = 28 n, %
Lay caregivers
Instrumental support: Tangibly helping patients through taking relevant actions:
For daily living Providing support relevant to maintain daily lives of patients, including driving, cooking, getting groceries,
and fulfilling daily practical needs
16, 57.1%
For financial matters Supporting patients with expenses related to alloHCT treatment 4, 14.3%
For medication intake Supporting patients with medication-related tasks, including taking medications, reminding of doses,
refilling, and picking up the medications
26, 92.9%
Emotional support Supporting patients by expressing words of encouragement, empathy and caring 11, 39.3%
Informational support Lay caregivers were not the primary sources of informational support, but they helped as memory
facilitators and conveyers of information from the healthcare providers
1, 3.6%
Ambivalence about receiving support Support attempts that were not perceived as helpful or relevant to patients 7, 25%
Healthcare Providers
Informational support: Providing relevant information about survival and self-care after discharge
Medications Any relevant information about prescribed medications, including their functions, dosing information, side
effects, and how to take them
23, 88.5%
Self-care Information relevant for self-care (other than medication intake) included guidelines for nutrition and
hydration
6, 23.1%
Support for medical needs Helping patients practically to fulfill their medical needs through relevant actions (e.g., refill medications on
time), which often made patients feel emotionally supported and cared for
18, 69.2%
Emotional support Providing words of encouragement, making patients feel cared, which contributed to a trusting relationship
between healthcare providers and patients
9, 34.6%
would be infection free or decrease the chances of infection. (P20,
male)
Another participant said that his wife makes sure to provide
food and drinks that are nutritious and hydrating, yet very
enjoyable and creative.
My wife was coming up with creative things, too. I started running
out of ideas. She found things at Whole Foods like chicken potpie
and roasted vegetable pot pie. I had a lot of stuff like that. It was
very flavorful. (P10, male)
His wife also provided him with different drinks to make sure
he stayed hydrated. “I’m very aware of having to hydrate because
of these drugs. It’s also part because of my wife. She buys creative
food things for recipes and different drinks.” (P10, male)
One participant suffered from stomach issues that made her
nauseous, and her husband cooked food that was easy to swallow
and digest. She said,
Husband does all the homework. He cooks, I don’t. Doctor doesn’t
want me to have outside food. We eat together, every 2 to 3 hours
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I have to eat, unless I have a stomach problem. It’s the time when
I am going to eat. Some snack: rice cake, I am [Asian]. (. . .) Every
2 hours I ate rice cooked with lots of water. Don’t have to chew; I
was able to eat just a little bit, every 2 hours. (P11, female)
Instrumental support with financial matters is critical for
patients as hematopoietic cell transplant is expensive and requires
an extensive treatment process over a long period of time, often
creating financial hardship for individuals and their families after
transplant (Khera et al., 2014; Kim et al., 2015). Instrumental
support with financial matters helped individuals to ameliorate
their financial burdens, as well as their emotional stress and
anxiety, as explicitly mentioned by some (n = 4/28, 14.3%).
One mentioned, “I don’t even know where the bills are. I
think he doesn’t want me to know because he doesn’t want
me to worry.” (P07, female). Moreover, lay caregivers needed to
balance the need for financial support with caring for individuals
after transplant.
She has her own business, but she works from home. Financially
we weren’t fantastic but no, she didn’t work a lot. She was kind
of holding it all together. While I was at the hospital, she was not
focusing on work at all. (P10, male)
Instrumental support for medication intake is another critical
area in which patients need help, as individuals after transplant
must take numerous medications even after a successful
transplant and discharge from the hospital. Medication-related
tasks are critical yet difficult for individuals after alloHCT
due to the number and complexity of medications. Nearly all
individuals in the sample (n = 26/28, 92.9%) mentioned that
their lay caregivers helped with medication-related tasks, such as
taking medications, reminding of doses, refilling, and picking up
the medications.
Every 2 and 3 hours I have to take the medication. I have to
be aware of the time and take and my husband reminds me. In
6 months, I have only missed one tablet. (P11, female)
She also mentioned that she was able to refill medications on
time because of her partner’s support: “[My] husband calls the
pharmacy, they send us FedEx.” (P11, female)
Emotional support, such as expressing encouragement,
empathy and caring, plays a significant role in helping individuals
after transplant as patients after alloHCT become physically and
emotionally vulnerable (Rini et al., 2011). More than half of the
participants reported receiving emotional support (n = 11/28,
39.3%). “As soon as I went into the hospital, my husband put up
a website for me because everyone called. So many people wrote
in, it was wonderful” (P07, female). Internet and technology
development have also facilitated emotional support. “I stay
home, but I’m not alone a lot. I do have friends who drop in a
lot. We have a lot of support. And I Skype a lot, everybody has
that all over the world.” (P07, female)
For emotional support, individuals after transplant rely on
a broader range of support sources than for instrumental
support, including members of their extended family, friends,
and acquaintances. In one case, an individual relied more
on friends for emotional support than family members and
distinguished the different types of support she received.
They really support me in every way, my friends and my family.
But for the medication, it’s my family, my husband and my little
ones, they remind me all the time, but emotionally, my friends,
they help me, like when I’m not feeling too up to it, or if I don’t
have, like, enough energy they help me a lot. (P22, female)
Individuals after transplant also perceive the importance
of receiving emotional support. An individual after transplant
suggested to other patients,
To be able to talk about your problems, talk with friends and
family. I would [be] trying to get them involved in a support
group. I am lucky to have a very supportive family and friends,
so I didn’t have to go out of my shell. You want people to ask how
you are doing. You need someone who is patient enough to listen.
(P07, female)
Informational support was not reported from lay caregivers
(n = 0.0%) as healthcare providers were the primary source
of informational support, but lay caregivers helped as memory
facilitators and conveyers of information from the healthcare
providers. In one interview the caregiver interrupted to
provide the correct response when the patient was asked what
medications he had to take on an empty stomach. The wife
interrupted that “the only one that he takes on an empty stomach
is Prilosec” (P25, male). This response indicates that she helped
the patient to remember the information. One patient (n = 1/28,
3.6%) mentioned her “husband keeps asking doctors about [side
effects of medications]” (P07, female). In this case, the patient’s
husband helped the patient by clarifying and reiterating the
information received from the doctors and also asked further
questions that the patient might have missed or forgotten to
ask. All other participants sought information either by using
online resources or directly asking their healthcare providers.
One person mentioned, “most of the teaching [is through] the
doctors, and the nurses. And I also go online sometimes and do
my little own research.” (P22, female)
Support attempts were not helpful to all individuals and
some patients expressed ambivalence about support from others
(n = 7/28, 25%). One participant chose not to share his situation
with the people around him at all, believing that it would only
cause more trouble.
I’m a public figure, I kept it secret for a long time, (. . .) Keeping it
secret: if I told them they were going to worry. They would want
me to take medication they know about. Take this, take that. I
[had] not wanted to deal with all that advice. Listen, I have my
doctors. You guys, just pray, don’t try to be my doctors. (P19,
male)
Four patients expressed that they did not like the feeling
of being monitored by their lay caregivers. They sought
independence and control over their situation, though to no avail.
In these cases, less support may be better. They perceived actions
of support not as helpful, but somewhat unpleasant and even
troublesome. An individual mentioned,
My wife asks me all the time whether I’m taking medications,
whether I took the medications, but basically I just think she’s
asking too much because I’m just taking it. (P13, male)
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One mentioned that he does not take medications when
he is bothered by other people (P17, male). The degree
of support received, and the quality of relationships varied
among individuals.
In another case, the support from lay caregivers was
ambiguously helpful. A participant mentioned the clothes she is
accustomed to wearing:
My sister doesn’t want me to use that, she buys new clothes. I
want the old clothes. She said I cannot use it anymore. Where is
it what I like. Even [the clothes] is old [in] our thinking, I will go
to the dry cleaning, wash and dry clean. I don’t know where the
clothes are. She is hiding clothes away. I don’t know where they
are (P29, female).
Characteristics of Healthcare Providers
We found that all participants asked about healthcare providers
identified them as a source of support (100% of 26 interviews).
Participants referred specifically to doctors and nurses when
speaking about healthcare providers. At the hospital, clinical
interdisciplinary teams worked closely together. Therefore,
most individuals after transplant perceived them as a team
(n = 22/26, 84.6%).
Nearly all individuals reported having a good relationship
with their healthcare providers and evaluated the relationship
as positive (n = 24/26, 92.3%). The quality of the patient-
healthcare provider relationship influenced individuals’ health
behaviors, especially with regards to making medical decisions.
When patients built trusting relationships with their healthcare
providers, they felt confident following their healthcare providers’
guidelines. One individual mentioned, “I’m a believer, I believe in
him. First thing we do in any situation that you want to get help
you have to believe. I believe in him. So what he says is right.”
(P17, male) Another individual also mentioned,
Very simply, they have my best intentions in mind, and they
override what do you call it. they know what the right thing to
do is, whether I like it or not. So they’re not sticking me with bad
tasting medications on purpose to make me feel bad. This is the
right thing to take. They’re the experts, they know the conditions,
they know what’s coming. (P13, male)
At the same time, one participant (n = 1/26, 3.8%),
while mentioning he did receive some support from his
healthcare providers, also expressed that he had received too
little information at the discharge meeting and was therefore
dissatisfied with the healthcare providers. He said,
I ended up back in here [admitted to the hospital]. They didn’t
talk about hydration. (. . .) Hydration is likely a bigger deal than
they tell you about. I was back in for 12 days. I was berserk about
that. (P01, male)
Another patient was ambiguous in her response regarding the
relationship with healthcare providers and did not quite perceive
a relationship: “Well, I have not had problems with them. I don’t
care.” (P12, female)
Types of Support From Healthcare Providers
Individuals after transplant perceived that their healthcare
providers mostly provided informational support in line with
their expertise. However, many individuals mentioned that
they also received other types of support from the healthcare
providers, including emotional support. We will present specific
examples detailing the kinds of support provided and how they
helped patients after transplant (see Table 3 for an overview).
Individuals after transplant mostly received informational
support from healthcare providers (n = 23/26, 88.5%). A wide
spectrum of healthcare providers, including pharmacists,
dietitians, hematologists and specialist nurses, provided
informational support verbally and in writing. Patients received
information on medications (n = 23/26, 88.5%) and nutrition,
including hydration (n = 6/26, 23.1%).
One participant reported that the relationship with healthcare
providers made it easier to take medications.
Because they tell me exactly that I need to take them, why I need
to take them, yeah always teaching. Always teaching, yup. Every
single day, every single appointment. The nurse coming first goes
over all of the medication and the doctor will do the same thing.
(P22, female)
Many patients reported that their health providers met their
medical needs (n = 18/26, 69.2%). One individual mentioned,
“They make sure that all my medical needs are met so I can
recover and go back to a regular life.” (P14, male). Another
patient recalled the help she received when she forgot to refill
her medications on time and needed an immediate supply. “I
have run out of the Prograf and that is very important, but the
doctors called in a 4-day refill script to [name of pharmacy 6] and
I picked it up.” (P31, female). Often, support for medical needs
was combined with emotional support, as a female participant
reported in dealing with her difficult stage four GvHD. She said,
One of the reasons, I have to tell you, are the [name of hospital
1] nurses. They are angels. They packed me in ice at night. They
looked at me, my skin was peeling, you couldn’t touch me any
place without me screaming because it hurt so much. It’s very good
to have nurses that are so kind. They actually stayed with me. They
didn’t have to do more than just come when I rang the bell. It’s
harder at night because everything is so quiet, and nothing can
distract you from the pain. (P07, female)
Healthcare providers, usually nurses, were also the sources
of emotional support, encouraging individuals after transplant
and showing care for their personal lives (n = 9/26, 34.6%).
The attitude of healthcare providers and the way individuals
after transplant perceived them influenced them in their recovery
process. As one participant noted,
In the sense that they know things are important, they make me
feel like my recovery is important, they make sure that all my
medical needs are met so I can recover and go back to a regular
life. (P14, male)
Another participant said,
I think the best thing was speaking with all the nurses. Becoming
friendly with them. (. . .) Yeah, and the day I left the hospital was
my birthday and they brought me a birthday cake. I can’t believe
they did that! So that was nice, that brightened up my day. (P43,
female)
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Emotional support contributed to a good and trusting
relationship with healthcare providers, encouraging and helping
individuals after transplant to recover. None of the patients
expressed ambivalence about support from healthcare providers
(n = 0/28, 0%).
Discussion
Study 2 explored the sources and functions of social support
for adherence to recommended self-care in individuals after
alloHCT. In line with a previous study, the role of lay caregivers is
critical for patients after alloHCT as they closely support patients
with managing home care and other daily tasks after transplant
(Posluszny et al., 2018). Moreover, healthcare providers played an
important role in providing information regarding medications
and self-care after discharge. They supported patients with
medical needs and also cared and comforted them. Our
findings suggest that these support sources serve complementary
functions. While emotional and instrumental support is largely
within the domain of lay caregivers, medical needs and
informational support are mostly provided by healthcare
providers. Thus, patients must coordinate support-seeking from
both lay caregivers and healthcare providers to facilitate multiple
medication intake and self-care after alloHCT.
General Discussion
The current study examined the importance of social support
in patients after alloHCT. Both quantitative and qualitative data
suggest the importance of social support to enable patients
to maintain a complex self-care regimen related to infection
prophylaxis and survival. Study 1 found that the presence of a
dedicated lay caregiver is related to improved chances of survival
after alloHCT, supporting previous findings (Beattie et al., 2013;
Foster et al., 2013; Ehrlich et al., 2016; Harashima et al., 2019) and
Study 2 examined the different types of support provided by lay
caregivers and healthcare professionals. Our findings suggest that
lay caregivers and healthcare providers each serve the patients in
different ways. Moreover, the different sources and networks of
social support in Study 2 (see Figure 1) suggest that information
on marital status misses the contribution of other lay caregivers,
which may explain why these studies found no link between
marital status and survival (Gerull et al., 2017; Sato et al., 2018;
Tay et al., 2020). More nuanced measures of support than marital
status should be considered for future research.
The difficulties of recovery after transplant, often
characterized by severe complications, patients feeling unwell,
fatigued, and socially limited due to their immunosuppressed
state, make caregiver support essential for day-to-day living (So
et al., 2003; Soubani, 2006; Rini et al., 2011; Wulff-Burchfield
et al., 2013; Posluszny et al., 2018). Financial support seems
essential for patients after alloHCT (Preussler et al., 2019). Our
culturally diverse sample showed a uniformly high reliance
on social support, although ethnicity and cultural background
played a role in providing appropriate concrete supportive
acts (e.g., support for adequate nutrition and hydration with
buying bread and soft drinks vs. cooking rice with lots of
water). Furthermore, caregivers’ presence motivated patients
and gave them reasons to live despite their difficult health
condition, supporting prior research (Krause, 2007). We
assume that this mechanism is also true for lay caregivers
who were shouldering a high caregiver burden in meeting
the considerable physical, financial, and emotional needs of
individuals after transplant. The presence of their loved ones,
despite their worsened health condition, may give meaning to
caregivers’ own lives. Efforts made by healthcare providers to
support patients were deeply appreciated by participants. In
line with prior research, caring and trusting patient-provider
relationships foster patients’ adherence to recommended self-
care (Haskard Zolnierek and DiMatteo, 2009; Hillen et al., 2010;
Espinosa and Kadić-Maglajlić, 2019).
There are several limitations to these studies. First, both
studies were conducted in a single treatment center in a large
urban area over a limited period of time. The findings may not
be generalizable beyond this setting and time period. However,
the diversity of the sample regarding ethnic background and
age range makes it likely that the findings will be more widely
applicable. Second, Study 2 may show some sampling biases,
as participants who volunteered to enroll and be interviewed
could differ from those not enrolled or interviewed (e.g., in
health or adherence). We tried to limit bias by inviting everyone
who was eligible and scheduled to receive an alloHCT. Another
potential bias is that individuals may have provided socially
desirable responses during the interviews. However, participants
were highly motivated and passionate about contributing to
the study to improve care for future transplant recipients and
often contributed more than we asked (e.g., by sending pictures
of their numerous pill containers). Therefore, we assume that
many participants responded with earnestness and sincerity.
In future research, interviewing the caregiver could give an
additional validation of patients’ reports and a complementary
perspective (Posluszny et al., 2018). Third, the treatment center
we collaborated with required nominating a dedicated support
provider in order to receive an alloHCT, as is common practice
(National Marrow Donor Program, 2017; Preussler et al., 2019).
Thus, the majority of patients in Study 1 and 2 had a dedicated
caregiver, and only a small group of patients had limited or
no support. Future studies in treatment centers which do not
require a caregiver may observe stronger effect sizes than those
observed in this study. However, we observed variability in
support in Study 1 and 2; despite the efforts of the hospital,
some caregivers do not fulfill their role. Anecdotally, during data
collection for Study 2, we received consent from two individuals
whose lay caregiver support was minimal, and both patients
passed away before we could interview them. These two cases,
in addition to our observations of the high support needs of
our participants, illustrate the difficulty of adhering to the self-
care recommendations and the multiple medication regimen
without a rigorous support system, with severe consequences
for survival. Fourth, in the chart review in Study 1 the research
team was able to merely establish the presence of a caregiver
but was not able to determine more information about the
quality of support (e.g., if there were other caregivers involved
and with what frequency and duration caregivers were available,
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as others have done; Foster et al., 2013). In Study 2, we
were able to describe the sources and functions of support in
detail, but the sample was too small to examine the link with
survival. Therefore, the conceptual linkages between types of
support and impact on survival are merely suggestive and require
further research.
Despite these limitations, this article has several strengths.
First, this article contributes to previous literature that support
truly matters for survival (Beattie et al., 2013; Foster et al., 2013),
using both quantitative and qualitative data. Study 1 underscored
the essential role of support, while Study 2 provided a nuanced
description of the characteristics of support providers and types
of support. The availability of support may influence survival
in two ways. Support may impact adherence to a complex self-
care regimen with quality of life. Support may also help patients
find meaning in life and carry on despite facing a high risk
of mortality and challenges with quality of life. Second, this
article contributes to the evidence base of a less frequently
studied cancer population (i.e., blood and lymphoid cancer
patients after alloHCT), where there is to our knowledge just
one other study of patient-caregiver responsibilities (Posluszny
et al., 2018). Finally, to facilitate adherence to this complex
self-care regimen, all three parties—the transplant recipient, lay
caregivers, and the healthcare providers—must work together
as a team. A prior systematic literature review showed that
social support from family members increases medication
adherence (DiMatteo, 2004), but does not focus on healthcare
providers. Our findings suggest the importance of support from
healthcare providers who should be considered part of the patient
support team.
Based on our findings, we propose a process model of
social support for patients who need to perform a complex
self-care regimen, which needs to be tested in future studies
and could inform intervention development (see Figure 2).
The figure represents the interactions among the support
triad of healthcare providers, lay caregivers, and patients,
and the functions of social support from each source. Based
on a strong foundation of trust, healthcare providers are
mainly responsible for providing professional informational
support regarding prescribed medications and medical needs,
and effectively communicating this information to patients
and lay caregivers. Lay caregivers provide more intimate,
daily instrumental support, such as refilling and organizing
medications, managing financial matters, cooking, and helping
with physical distancing. They are also the major sources
of emotional support, encouraging and comforting patients,
which helped patients to maintain a positive and optimistic
attitude toward their recovery. We propose that the different
types of support are partly co-occurring and intertwined
(e.g., with actions of practical support expressing a lay
caregiver’s love for the patient) and that there may be an
interactive effect between different types of support that deserves
further research.
Our findings—although they are based on a limited sample
size from a single transplant center—highlight the importance
of measures that many transplant centers already implement in
their clinical care to ensure adequate support for individuals
after transplant. To ensure that patients and caregivers can
follow the complex self-care regimen, healthcare providers need
to devote time and attention to conveying the details about
the relevant self-care tasks. Although transplant clinics already
provide relevant education sessions to patients and caregivers,
consistent implementation is critical, and it might be also helpful
to repeatedly check on the availability of caregiver support
throughout treatment even after discharge (Preussler et al., 2019).
A scheduled dedicated prescription meeting delivered by a nurse
FIGURE 2 | Cascade of social support tasks to ensure adequate self-care.
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or a pharmacist in the presence of both patient and caregiver
was helpful to the participants in this study who received it.
Second, the requirement to nominate a dedicated lay caregiver
after transplant seems to be warranted. Third, social support is
essential for following a self-care regimen. If providers of social
support cannot attend the prescription meetings, they should be
informed about the patient’s support needs via a phone call or
at least by a written letter. Lastly, we suggest the need for more
clinical interventions and possibly policy implementations as
some question whether poor social support should keep patients
from receiving a transplant (Sharma and Johnson, 2019).
CONCLUSION
In conclusion, this study contributes to a more detailed
theoretical and practical understanding of social support for a
complex self-care regimen. To the best of our knowledge, this
is amongst the first in-depth investigation of support, survival
and self-care in patients after alloHCT. The teamwork of patients,
lay caregivers, and healthcare providers is the basis for successful
survival after transplant. Based on our findings, healthcare
providers and lay caregivers must work in tandem to promote
adherence to self-care regimens. The results of this study also
suggest that there is a need to develop interventions for patients
and their caregivers to facilitate treatment adherence for survival.
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